Work

P3.18.42 Camrelizumab Combined With Chemotherapy and Local Consolidative Therapy for Untreated Oligometastatic NSCLC With PD-L1 Expression <50%

Year: 2025
Type: article
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: bronze
OpenAlex ID: W4415519206
FWCI:
Cites:
Cited by:
Related to: 10